21229 ⎘
Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Immunity inducer for saccharide antigens
#302Methods and compositions related to immunogenic fibrils
#303Individualized vaccines for cancer
#304Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates
#305Methods for improving immunological response in vaccinated animals
#306Conjugation of type 8 capsular polysaccharides
#307Conjugate vaccine using trimming function of ERAP1
#308Immunogenic composition in emulsion form
#3096-acetylmorphine analogs, and methods for their synthesis and use
#310Compositions and methods for preparing serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
#311Siderophore-based immunization against gram-negative bacteria
#312ANTIBODIES TARGETED TO FUNGAL CELL WALL POLYSACCHARIDES
#313Glycotargeting therapeutics
#314HER-1, HER-3 and IGF-1R compositions and uses thereof
#315Conjugate compounds
#316Compositions and methods using recombinant MHC molecules for the treatment of stroke
#317Immunomodulatory agent-polymeric compounds
#318Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof
#319Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
#320Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#321Pneumoccal polysacchride conjugate vaccine
#322Covalently linked antigen-antibody conjugates
#323Re-directed immunotherapy
#324Carbohydrate-glycolipid conjugate vaccines
#325Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#326Conjugation of streptococcal capsular saccharides
#327Glycoconjugation processes and compositions
#328Methods and compositions for treating multiple sclerosis and related disorders
#329Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#330Bacterial biofilm matrix as a platform for protein delivery
#331Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein
#332Compositions and methods
#333Recombinant polypeptide construct comprising multiple enterotoxigenic fimbrial subunits
#334Recombinant polypeptides comprising MHC class II α1 domains
#335Modified coiled coil type proteins having improved properties
#336IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO
#337Universal carrier for targeting molecules to GB3 receptor expressing cells
#338Immunogenic composition
#339Conjugating amines
#340Immunogenic compositions and reagents for preparing
#341Immunogenic composition
#342Erythrocyte-binding therapeutics
#343Nanoparticle-peptide compositions
#344Method of detecting the presence of an antibody in a sample
#345Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (PRRS)
#346Activation of polysaccharides via the cyanylating agent, 1-cyanobenzotriazole (1-CBT), in the preparation of polysaccharide/protein conjugate vaccines
#347Polysaccharide-protein conjugate vaccines
#348Activation of polysaccharides via the cyanylating agent, 2-cyanopyridazine-3(2H)-one (2-CPO), in the preparation of polysaccharide/protein conjugate vaccines
#349Activation of polysaccharides via the cyanylating agent, 1-cyanoimidazole (1-Cl), in the preparation of polysaccharide/protein conjugate vaccines
#350Methods and compositions for liposomal formulation of antigens and uses thereof
#351CD4+ T-cells with cytolytic properties
#352Multiple antigen presenting immunogenic composition, and methods and uses thereof
#353Antigen presenting cell targeted anti-viral vaccines
#354Method of developing a vaccine using peptide-poly IC complexes
#355Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
#356Polyvalent conjugate vaccine for cancer
#357Protein complex system for increased immunogenicity and functionality, and methods making and use
#358IgE CH3 peptide vaccine
#359Re-directed immunotherapy
#360Conjugation process
#361Reversible protein multimers, methods for their production and use
#362Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
#363Conjugates comprising an -oxime bond and associated methods
#364Peptides, conjugates and method for increasing immunogenicity of a vaccine
#365VACCINE COMPOSITIONS
#366ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM
#367Process for manufacturing vaccines
#368Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#369HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS
#370CHEMICALLY PROGRAMMABLE IMMUNITY
#371IgE CH3 peptide vaccine
#372Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines
#373Compositions and methods for preparing serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
#374Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
#375Polyvalent conjugate vaccine for cancer
#376Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain
#377Conjugation of type 5 and type 8 capsular polysaccharides
#378Molecular Antigen Array
#379Polysaccharide-protein conjugate vaccines
#380Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
#381Methods and systems for inducing immunologic tolerance to non-self antigens
#382VACCINE AGAINST BOTULISM
#383Method for preparing recombinant antigen complex using rotavirus nanoparticle
#384Molecular Antigen Array
#385Conjugates for the prevention or treatment of nicotine addiction
#386Capsule composition for use as immunogen against
#387Broad spectrum vaccine against non-typhoidal
#388Conjugates comprising mannan and myelin oligodentrocyte glycoprotein (MOG)
#389Compositions and methods using recombinant MHC molecules for the treatment of stroke
#390Vaccine
#391IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING
#392CD4+CELLS WITH CYTOLYTIC PROPERTIES
#393Angiotensin peptide-carrier conjugates and uses thereof
#394COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#395Recombinant toxin fragments
#396Immunomodulatory agent-polymeric compounds
#397TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS
#398VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#399Oral delivery of tetanus toxoid
#400NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE
#401Anti-CD40 targeted fusion proteins
#402Fusion protein with HIV antigen
#403Compositions and Methods
#404Chemically programmable immunity
#405Method of immunizing humans against using a Vi-EPA conjugate vaccine
#406Methods and compositions for liposomal formulation of antigens and uses thereof
#407Process for manufacturing vaccines
#408Universal carrier for targeting molecules to Gb3 receptor expressing cells
#409MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES
#410IgE CH3 peptide vaccine
#411Process for manufacturing vaccines
#412Method for Preparing a Covalently Cross Linked Oligomer of Amyloid Beta Peptides
#413Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#414Antigen conjugates and uses thereof
#415Human papillomavirus / Ii-Key hybrids and methods of use
#416Pneumococcal polysaccharide conjugate vaccine
#417Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates
#418Methods for preparing immunogenic conjugates
#419Induction of an immune response against streptococcus pneumoniae polyaccharides
#420COMPOSITIONS FOR INDUCING IMMUNE RESPONSES SPECIFIC TO GLOBO H AND SSEA3 AND USES THEREOF IN CANCER TREATMENT
#421VACCINE
#422Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
#423Recombinant toxin fragments
#424HER-2/NEU MULTI-PEPTIDE VACCINE
#425Immunogenic composition
#426Recombinant toxin fragments
#427Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
#428Combination vaccines with whole cell pertussis antigen
#429ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES
#430Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#431Compositions and methods for the prevention and treatment of autoimmune conditions
#432Recombinant toxin fragments
#433Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic
#434Immunogenic composition
#435T-Cadherin antigen arrays and uses thereof
#436Non-Natural Amino Acid Polypeptides Having Modified Immunogenicity
#437Polyvalent conjugate vaccine for cancer
#438Conjugation of streptococcal capsular saccharides
#439Immunogenic composition
#440Vaccine
#441Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide Conjugates
#442SKIN IMMUNIZATION USING LT-STA FUSION PROTEINS
#443Pneumococcal Polysaccharide Conjugate Vaccine
#444Anti-malaria vaccine
#445PROTEIN CAGE IMMUNOTHERAPEUTICS
#446Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
#447Molecular antigen arrary
#448Method of producing conjugate vaccines
#449Immunogenic composition
#450Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines
#451Immunogenic composition
#452METHODS AND COMPOSITIONS FOR INCREASED PRIMING OF T-CELLS THROUGH CROSS-PRESENTATION OF EXOGENOUS ANTIGENS
#453Yeast Cell Particles As Oral Delivery Vehicles For Antigens
#454Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
#455Conjugation of biomolecules using Diels-Alder cycloaddition
#456HBV core antigen particles with multiple immunogenic components attached via peptide ligands
#457Immunogenic Hiv Compositions and Related Methods
#458Recombinant toxin fragments
#459Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
#460Methods for reducing nasopharyngeal colonization of non-typable with synthetic chimeric fimbrin peptides
#461Anti-amyloid immunogenic compositions, methods and uses
#462Recombinant toxin fragments
#463Method of immunizing humans against using a Vi-EPA conjugate vaccine
#464Polysaccharide-protein conjugate vaccines
#465Immunogenic peptide carrier conjugates and methods of producing same
#466Antigen arrays for treatment of bone disease
#467Antigen arrays for treatment of allergic eosinophilic diseases
#468Angiotensin peptide-carrier conjugates and uses thereof
#469Injectable vaccines against multiple meningococcal serogroups
#470Conjugate vaccines for the prevention of dental caries
#471Molecular antigen array
#472Anti-allergic complex molecules
#473Carrier of a diamond fine particle for immobilizing virus
#474Hetero type pentamer recombinant vaccine
#475Gp120 specific antigens and uses thereof
#476Prostate specific antigens and uses thereof
#477Flexible vaccine assembly and vaccine delivery platform
#478Polysaccharide and glycoconjugate vaccines
#479Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
#480Conjugated hydroxyalkyl starch allergen compounds
#481Active and passive immunization against pharmacologically active hapten molecules using a synthetic carrier compound composed of similar elements
#482Recombinant toxin fragments
#483Angiotensin peptide-carrier conjugates and uses thereof
#484Targeted immunogens
#485Methods for preparing immunogenic conjugates
#486Recombinant toxin fragments
#487Methods and compositions comprising bacteriophage nanoparticles
#488Heat shock protein-based vaccines and immunotherapies
#489Immunogenic HIV compositions and related methods
#490Polysaccharide vaccine for staphylococcal infections
#491Vaccine for treating nicotine addiction
#492Methods and compositions for inducing autoimmunity in the treatment of cancers
#493Process for preparing conjugate vaccines and the conjugate vaccines
#494Covalently modified antigens for improved immune response and/or stability